160 likes | 225 Views
SpineMatrix has developed the Lumbar Matrix System, a unique imaging scan for disc, facet, and chronic LBP diagnosis. With patented technology, FDA approval, and clinical papers, it adds value to the company. Targeting surgeons, it addresses the need for improved diagnostics in spinal care. Supported by experienced CEOs and financing, it aims to revolutionize the spine market with cost-effective, outcome-focused solutions.
E N D
Product • SMI has developed the Lumbar Matrix System • A unique spinal physiology imaging scan used to diagnose disc, facet and chronic LBP pathology • SMI is the only company that offers this technology • 10 issued US Patents (1 pending) • 5 issued foreign patents (1 pending) • FDA approved • UL approved • 4 functional CPT reimbursement codes • 10 peer-reviewed published clinical papers SpineMatrix
We manufacture our own arrays • We will begin manufacturing our hardware/software systems in July • Control of vendors and W.I.P., provides as-needed inventory management • Adds significant value to the company SpineMatrix
Stage of Company • Launched the LMS System in February SpineMatrix
Customers • Neuro and orthopaedic spine surgeons • LMS usage cascade of treatment (when and how) SpineMatrix
Creation of Company • Technology Founder - Mark Finneran, MD Wooster, Ohio • Trained neurosurgeon / rehabilitation physician who saw the need • 30-40% of L.B. spine surgeries result in “failed back syndrome” • Clearly points to the need for improved diagnostic and better defined treatment pathways SpineMatrix
Market Demand • Large, strong market demographics • 21 million LBP hospital visits per year • $145 billion spent annually on LBP patients resulting in 1.5 million spinal surgeries • 60-65% success rate SpineMatrix
Entrepreneur/CEO Market Exposure • Twenty-Five Years experience in the ortho/spine marketplace • Theken Spine – President • Wright Medical Spine, Trauma, Biologics, Sr. VP • Medtronic Sofamore Danek, VP SpineMatrix
Financing • Series A ($9.5 MM) • NationWide Insurance (OH) • ABL Group (OH) • Z2 Ventures (OH) • X-Gen (OH) • Ohio Innovation Fund (OH) • Dan Kellogg (OH) • Series B ($8 MM) • Psilos Group (NYC) (lead) • ODOD (OH) • ABL Group (OH) *Follow-on is available SpineMatrix
Original Business Plan • To outsource development and manufacturing • Launch in the rehabilitation/workers’ comp. markets • Utilize Independent distribution network SpineMatrix
Revised Business Plan • In-house manufacturing control • Target neuro/ortho spine surgeons • Utilize published and defined clinical support data • Direct sales organization SpineMatrix
Future • Large Market • Advantage-current cost savings environment for medical procedures • Need for outcome-focused reproducible results • No current competition for LMS System SpineMatrix
Impact Of NE Ohio On Company • Governor Strickland, Lt. Governor Fisher and ODOD – very supportive • Akron Mayor Donald Plusquellic and his staff – very supportive • BioEnterprise Interaction SpineMatrix
Challenges • Recruiting at the Sr. Management level • Medical device vendors and contract Manufacturing base to service small companies • Overall economic trends in the Akron region • Lack of larger (lead) VC firms in Ohio that focus on medical devices and have significant follow-on capacity SpineMatrix
Lessons Learned / Business Plan • Never assume that previous device development and manufacturing data has value • Adoption curve for something brand new • Issues with third-party payers SpineMatrix